Tirzepatide vs. semaglutide — what's the difference?
The core difference is how they work. Tirzepatide is a dual agonist — it acts on both the GIP and GLP-1 receptors — while semaglutide acts on the GLP-1 receptor alone. Both are once-weekly injections used for weight management, but the dual-receptor action is what distinguishes tirzepatide. Which one is right for you is a decision to make with your provider based on your history and goals.
How much weight can I expect to lose?
Results are highly individual and depend on your starting point, dose, how far you titrate, and the nutrition and activity changes you make alongside the medication. Some people lose more on tirzepatide than on single-agonist GLP-1s, but there are no guarantees — your provider will help set realistic, personalized expectations.
What are the side effects, and how do I manage nausea?
The most common side effects are gastrointestinal — nausea, diarrhea, constipation, and reduced appetite — and they're usually mild and tend to ease as your body adjusts. Starting low and titrating slowly is the main way nausea is minimized. Eating smaller, lower-fat meals and staying hydrated can help, and anti-nausea support is available through your care team if needed.
How is tirzepatide taken, and how often?
Tirzepatide is a once-weekly subcutaneous injection — taken on the same day each week, with or without food. Your provider sets your starting dose and titration schedule and adjusts it over time based on your response and tolerance.
Why does the dose start low and go up?
Titration — starting at 2.5 mg and stepping up gradually over months — gives your body time to adjust and keeps gastrointestinal side effects more manageable. Increasing too quickly tends to worsen nausea, so your provider raises the dose in stages based on how you're tolerating it.
Do I need insurance?
No. ForbiddenRx works entirely without insurance — you complete an online visit and, if tirzepatide is appropriate, your medication ships directly to you. A prescription is not guaranteed and is subject to provider review of your health history.
